NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1

CUSIP: 64125CAD1

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Debt / NOTE 2.250% 5/1
Market price (% of par)
119.36%
Total 13F principal
$507,326,200
Principal change
+$10,812,750
Total reported market value
$604,492,120
Number of holders
51
Value change
-$14,518,958
Number of buys
17
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 64125CAD1?
CUSIP 64125CAD1 identifies 64125CAD1 - NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 as of Q4 2018

As of 31 Dec 2018, NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 was held by 51 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $507,326,200 in principal (par value) of the bond. The largest 10 bondholders included Allianz Asset Management GmbH, BAKER BROS. ADVISORS LP, FRANKLIN RESOURCES INC, Invesco Ltd., DLD Asset Management, LP, CALAMOS ADVISORS LLC, Linden Advisors LP, MACKAY SHIELDS LLC, UBS ASSET MANAGEMENT AMERICAS INC, and WELLS FARGO & COMPANY/MN. This page lists 51 institutional bondholders reporting positions for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.